Attovia Therapeutics, Inc. (ATTO)
Nasdaq · Biological Products, (No Diagnostic Substances) · Inc. DE
What they're doing
Between 2026-06-21 and 2026-09-19, public records show 18 signals for Attovia Therapeutics, Inc.. Most notable: 2026-08-06: 6 insiders bought $72.9M within 14 days; 2026-08-06: Frazier Life Sciences XI, L.P.; FHMLS XI, L.P.; FHMLS XI, L.L.C. (ten_percent_owner) bought $10.0M of stock; 2026-08-06: WALSH COLIN (director) bought $8.5M of stock. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.
Generated 2026-09-19 from public records.
Signals, last 12 months
- Insider buying cluster6 insiders bought $72.9M within 14 days
- Insider purchaseFrazier Life Sciences XI, L.P.; FHMLS XI, L.P.; FHMLS XI, L.L.C. (ten_percent_owner) bought $10.0M of stock
- Insider purchaseWALSH COLIN (director) bought $8.5M of stock
- Insider purchaseGOLDMAN SACHS GROUP INC; GOLDMAN SACHS & CO. LLC; GOLDMAN SACHS ASSET MANAGEMENT, L.P.; Broad Street Principal Investments, L.L.C.; WSLS OFFSHORE INVESTMENTS, SLP; West Street Life Sciences I, L.P.; WSLS EMP OFFSHORE INVESTMENTS, L.P.; WSLS EMP ONSHORE INVESTMENTS, L.P. (other) bought $8.5M of stock
- Insider purchaseWALSH COLIN (director) bought $8.5M of stock
- Insider purchaseGOLDMAN SACHS GROUP INC; GOLDMAN SACHS & CO. LLC; GOLDMAN SACHS ASSET MANAGEMENT, L.P.; Broad Street Principal Investments, L.L.C.; WSLS OFFSHORE INVESTMENTS, SLP; West Street Life Sciences I, L.P.; WSLS EMP OFFSHORE INVESTMENTS, L.P.; WSLS EMP ONSHORE INVESTMENTS, L.P. (other) bought $8.5M of stock
- Insider purchasevenBio Global Strategic Fund IV, L.P. (ten_percent_owner) bought $6.5M of stock
- Insider purchaseRedmile Group, LLC; Green Jeremy; Redmile Biopharma Investments III, L.P. (ten_percent_owner) bought $6.8M of stock
- Insider purchaseSanofi (ten_percent_owner) bought $5.1M of stock
- Insider purchaseRedmile Group, LLC; Green Jeremy; Redmile Biopharma Investments III, L.P. (ten_percent_owner) bought $3.4M of stock
- Insider purchaseGOLDMAN SACHS GROUP INC; GOLDMAN SACHS & CO. LLC; GOLDMAN SACHS ASSET MANAGEMENT, L.P.; Broad Street Principal Investments, L.L.C.; WSLS OFFSHORE INVESTMENTS, SLP; West Street Life Sciences I, L.P.; WSLS EMP OFFSHORE INVESTMENTS, L.P.; WSLS EMP ONSHORE INVESTMENTS, L.P. (other) bought $1.8M of stock
- Insider purchaseWALSH COLIN (director) bought $1.8M of stock
- Insider purchaseGOLDMAN SACHS GROUP INC; GOLDMAN SACHS & CO. LLC; GOLDMAN SACHS ASSET MANAGEMENT, L.P.; Broad Street Principal Investments, L.L.C.; WSLS OFFSHORE INVESTMENTS, SLP; West Street Life Sciences I, L.P.; WSLS EMP OFFSHORE INVESTMENTS, L.P.; WSLS EMP ONSHORE INVESTMENTS, L.P. (other) bought $1.8M of stock
- Insider purchaseWALSH COLIN (director) bought $1.8M of stock
- Large insider saleGOLDMAN SACHS GROUP INC; GOLDMAN SACHS & CO. LLC; GOLDMAN SACHS ASSET MANAGEMENT, L.P.; Broad Street Principal Investments, L.L.C.; WSLS OFFSHORE INVESTMENTS, SLP; West Street Life Sciences I, L.P.; WSLS EMP OFFSHORE INVESTMENTS, L.P.; WSLS EMP ONSHORE INVESTMENTS, L.P. (other) sold $1.6M of stock
- Large insider saleWALSH COLIN (director) sold $1.6M of stock
- Large insider saleGOLDMAN SACHS GROUP INC; GOLDMAN SACHS & CO. LLC; GOLDMAN SACHS ASSET MANAGEMENT, L.P.; Broad Street Principal Investments, L.L.C.; WSLS OFFSHORE INVESTMENTS, SLP; West Street Life Sciences I, L.P.; WSLS EMP OFFSHORE INVESTMENTS, L.P.; WSLS EMP ONSHORE INVESTMENTS, L.P. (other) sold $1.6M of stock
- Large insider saleWALSH COLIN (director) sold $1.6M of stock
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-08-06 | WALSH COLIN | director | C | 1,957,134 | 0 | $0 |
| 2026-08-06 | WALSH COLIN | director | C | 478,498 | 0 | $0 |
| 2026-08-06 | WALSH COLIN | director | P | 500,000 | 17 | $8,500,000 |
| 2026-08-06 | Sanofi | ten percent owner | C | 782,855 | — | — |
| 2026-08-06 | Sanofi | ten percent owner | P | 300,000 | 17 | $5,100,000 |
| 2026-08-06 | GOLDMAN SACHS GROUP INC; GOLDMAN SACHS & CO. LLC; GOLDMAN SACHS ASSET MANAGEMENT, L.P.; Broad Street Principal Investments, L.L.C.; WSLS OFFSHORE INVESTMENTS, SLP; West Street Life Sciences I, L.P.; WSLS EMP OFFSHORE INVESTMENTS, L.P.; WSLS EMP ONSHORE INVESTMENTS, L.P. | other | C | 1,957,134 | 0 | $0 |
| 2026-08-06 | GOLDMAN SACHS GROUP INC; GOLDMAN SACHS & CO. LLC; GOLDMAN SACHS ASSET MANAGEMENT, L.P.; Broad Street Principal Investments, L.L.C.; WSLS OFFSHORE INVESTMENTS, SLP; West Street Life Sciences I, L.P.; WSLS EMP OFFSHORE INVESTMENTS, L.P.; WSLS EMP ONSHORE INVESTMENTS, L.P. | other | C | 478,498 | 0 | $0 |
| 2026-08-06 | GOLDMAN SACHS GROUP INC; GOLDMAN SACHS & CO. LLC; GOLDMAN SACHS ASSET MANAGEMENT, L.P.; Broad Street Principal Investments, L.L.C.; WSLS OFFSHORE INVESTMENTS, SLP; West Street Life Sciences I, L.P.; WSLS EMP OFFSHORE INVESTMENTS, L.P.; WSLS EMP ONSHORE INVESTMENTS, L.P. | other | P | 500,000 | 17 | $8,500,000 |
| 2026-08-06 | WALSH COLIN | director | C | 1,957,134 | 0 | $0 |
| 2026-08-06 | WALSH COLIN | director | C | 478,498 | 0 | $0 |
| 2026-08-06 | WALSH COLIN | director | P | 500,000 | 17 | $8,500,000 |
| 2026-08-06 | GOLDMAN SACHS GROUP INC; GOLDMAN SACHS & CO. LLC; GOLDMAN SACHS ASSET MANAGEMENT, L.P.; Broad Street Principal Investments, L.L.C.; WSLS OFFSHORE INVESTMENTS, SLP; West Street Life Sciences I, L.P.; WSLS EMP OFFSHORE INVESTMENTS, L.P.; WSLS EMP ONSHORE INVESTMENTS, L.P. | other | C | 1,957,134 | 0 | $0 |
| 2026-08-06 | GOLDMAN SACHS GROUP INC; GOLDMAN SACHS & CO. LLC; GOLDMAN SACHS ASSET MANAGEMENT, L.P.; Broad Street Principal Investments, L.L.C.; WSLS OFFSHORE INVESTMENTS, SLP; West Street Life Sciences I, L.P.; WSLS EMP OFFSHORE INVESTMENTS, L.P.; WSLS EMP ONSHORE INVESTMENTS, L.P. | other | C | 478,498 | 0 | $0 |
| 2026-08-06 | GOLDMAN SACHS GROUP INC; GOLDMAN SACHS & CO. LLC; GOLDMAN SACHS ASSET MANAGEMENT, L.P.; Broad Street Principal Investments, L.L.C.; WSLS OFFSHORE INVESTMENTS, SLP; West Street Life Sciences I, L.P.; WSLS EMP OFFSHORE INVESTMENTS, L.P.; WSLS EMP ONSHORE INVESTMENTS, L.P. | other | P | 500,000 | 17 | $8,500,000 |
| 2026-08-06 | Deep Track Biotechnology Master Fund, Ltd.; Deep Track Capital, LP; KROIN DAVID | ten percent owner | C | 1,957,138 | — | — |
| 2026-08-06 | venBio Global Strategic Fund IV, L.P. | ten percent owner | C | 2,311,870 | — | — |
| 2026-08-06 | venBio Global Strategic Fund IV, L.P. | ten percent owner | C | 821,998 | — | — |
| 2026-08-06 | venBio Global Strategic Fund IV, L.P. | ten percent owner | C | 665,147 | — | — |
| 2026-08-06 | venBio Global Strategic Fund IV, L.P. | ten percent owner | P | 382,352 | 17 | $6,499,984 |
| 2026-08-06 | Redmile Group, LLC; Green Jeremy; Redmile Biopharma Investments III, L.P. | ten percent owner | C | 782,854 | — | — |
| 2026-08-06 | Redmile Group, LLC; Green Jeremy; Redmile Biopharma Investments III, L.P. | ten percent owner | P | 200,000 | 17 | $3,400,000 |
| 2026-08-06 | Redmile Group, LLC; Green Jeremy; Redmile Biopharma Investments III, L.P. | ten percent owner | P | 400,000 | 17 | $6,800,000 |
| 2026-08-06 | Frazier Life Sciences XI, L.P.; FHMLS XI, L.P.; FHMLS XI, L.L.C. | ten percent owner | C | 1,749,192 | — | — |
| 2026-08-06 | Frazier Life Sciences XI, L.P.; FHMLS XI, L.P.; FHMLS XI, L.L.C. | ten percent owner | C | 1,590,175 | — | — |
| 2026-08-06 | Frazier Life Sciences XI, L.P.; FHMLS XI, L.P.; FHMLS XI, L.L.C. | ten percent owner | C | 1,189,940 | — | — |
| 2026-08-06 | Frazier Life Sciences XI, L.P.; FHMLS XI, L.P.; FHMLS XI, L.L.C. | ten percent owner | C | 961,322 | — | — |
| 2026-08-06 | Frazier Life Sciences XI, L.P.; FHMLS XI, L.P.; FHMLS XI, L.L.C. | ten percent owner | P | 588,235 | 17 | $9,999,995 |
| 2026-08-05 | WALSH COLIN | director | S | 700 | 22.07 | $15,449 |
| 2026-08-05 | WALSH COLIN | director | P | 85,000 | 21 | $1,785,000 |
| 2026-08-05 | WALSH COLIN | director | S | 988 | 22.03 | $21,766 |
| 2026-08-05 | WALSH COLIN | director | S | 447 | 21.87 | $9,776 |
| 2026-08-05 | WALSH COLIN | director | S | 1,332 | 22.03 | $29,344 |
| 2026-08-05 | WALSH COLIN | director | S | 200 | 22.05 | $4,410 |
| 2026-08-05 | WALSH COLIN | director | S | 1,556 | 22.06 | $34,325 |
| 2026-08-05 | WALSH COLIN | director | S | 3,402 | 22.02 | $74,912 |
| 2026-08-05 | WALSH COLIN | director | S | 200 | 22.1 | $4,420 |
| 2026-08-05 | WALSH COLIN | director | S | 480 | 21.55 | $10,344 |
| 2026-08-05 | WALSH COLIN | director | S | 100 | 22.11 | $2,211 |
| 2026-08-05 | WALSH COLIN | director | S | 753 | 21.97 | $16,543 |
| 2026-08-05 | WALSH COLIN | director | S | 672 | 22.02 | $14,797 |
| 2026-08-05 | WALSH COLIN | director | S | 6,970 | 22.03 | $153,549 |
| 2026-08-05 | WALSH COLIN | director | S | 400 | 22.02 | $8,808 |
| 2026-08-05 | WALSH COLIN | director | S | 1,180 | 21.84 | $25,771 |
| 2026-08-05 | WALSH COLIN | director | S | 1,040 | 22.05 | $22,932 |
| 2026-08-05 | WALSH COLIN | director | S | 300 | 20.84 | $6,252 |
| 2026-08-05 | WALSH COLIN | director | S | 443 | 21.78 | $9,649 |
| 2026-08-05 | WALSH COLIN | director | S | 200 | 22.05 | $4,410 |
| 2026-08-05 | WALSH COLIN | director | S | 1,163 | 22.19 | $25,807 |
| 2026-08-05 | WALSH COLIN | director | S | 100 | 21.99 | $2,199 |
| 2026-08-05 | WALSH COLIN | director | S | 6,763 | 21.61 | $146,148 |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.